Go to Page # Page of 74

TTYBiopharm Company Overview

 Ralf Linker, Fred Lublin, Frederike Barkhof, Cai Qingbiao
  16th-Jun-2017
Description: The only PIC/S GMP certified manufacture sites for high potency oncology, 2008/2013/2016 EMA, 2010/2014 Japan, 2013/2016 US FDA, 2013 Brazil,Australia. High standard Validation of. Equipment qualification/ Laboratory instruments qualification/ HVAC system/ Water system/ Compressed air system/ Nitrogen system/ Cleaning/ Analytical method/ Process/ Computer/ Logistic.
Views: 1318
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: TTY Biopharm
 ‐ More of their Presentations
Contents:
May, 2017

2016- NTD 3.80 Billion, USD 117 Million
508
(March, 2017)










TTY Biopharm is a global leader in Super-Generic Drugs and
novel specialty/ bio-drug development with strong growth
potentials (targeting for 20% sales CAGR in 2014-19).
TTY is Taiwan’s largest biotechnology conglomerate with the
most completed biotechnology products pi ... See more

Recent Presentations

Advancing Digital Health in Canada

The myHealth Gateway app is a consumer facing mobile app that federates and provides a single access point for participating public and private sector services.

Susan Sepa
20 June, 2018
...
19 June, 2018
...
18 June, 2018